The Trump administration has suspended disbursement of funds from the PEPFAR program, crucial for H.I.V. treatment in Africa and developing nations. This 90-day halt, per an executive order on foreign aid, affects a program that has provided lifesaving treatment to 25 million people since its inception in 2003. Experts warn that this delay may result in treatment interruptions and promote drug-resistant H.I.V., endangering hard-won progress. The funding review could take up to 180 days, raising concerns about the future of H.I.V. efforts amidst changing political support within the administration.
"Any prolonged pause in funding could disrupt H.I.V. treatment programs, leading to treatment interruptions, rise of drug-resistant H.I.V., risking progress that we've made over decades to control the H.I.V. epidemic."
"Since its start in 2003, Pepfar is estimated to have delivered lifesaving treatment as many as 25 million people in 54 countries, highlighting its crucial role in global health."
Collection
[
|
...
]